Contact number
+1 212 209 4800Provided by Chambers
Brown Rudnick LLP has built a strong startups and emerging companies practice, advising a range of clients in early stage growth. The team advises startups, investors and venture companies across a range of industries including life sciences, artificial intelligence and cleantech. The law firm also provides international capabilities catering complex cross-border transactions.
Brown Rudnick represented Crossbow Therapeutics in connection with its $80 million series A financing. The funding round was led by MPM BioImpact and Pfizer Ventures, with participation from Polaris Partners, BVF Partners, Eli Lilly and Company, Mirae Asset Venture Investment, and Mirae Asset Capital.
Provided by Chambers
They have clear experience and empathy with the plight of managing early stage companies.
Brown Rudnick are highly engaged in all aspects of business.
They have clear experience and empathy with the plight of managing early stage companies.
Brown Rudnick are highly engaged in all aspects of business.
Provided by Chambers
Michael Cohen cochairs Brown Rudnick's emerging growth companies and venture capital practice. He is adept at advising clients across the technology and life sciences sectors.
Jared Sorin has a burgeoning practice in the space. His clients include venture funds and startup organizations. He has considerable experience of handling early-stage financings and formation issues.
Jared does a good job.